Application of Astragaloside I
Astragaloside I is a natural compound isolated from Astragalus.
Name Of Astragaloside I
English Name: 3-O-β-(2',3'-di-O-acetyl)-D-xylopyranosyl-6-O-β-D-glucopyranosyl-cycloastragenol
Bioactivity of astragaloside I
Description: astragaloside I is a natural compound isolated from Astragalus
Related Categories: signal path > > other > > other
Research field > > others
Natural Products > > terpenoids and glycosides
References:  JIN Yi-qun, et al. Determination of astragaloside-I content in Qidan Jiannao Granules with HPLC-ELSD. Acta Chinese Medicine and Pharmacology, 2006-02
. Wang chunhong, et al. Determination the Content of Astragaloside I in Shuxing Oral by Dual Wavelength TLC-Scanning. China Pharmacist, 2005-05
Physicochemical Properties Of Astragaloside I
Density: 1.4 ± 0.1 g / cm3
Boiling Point: 910.6 ± 65.0 ° C at 760 mmHg
Molecular Formula: C45H72O16
Molecular Weight: 869.04
Flash Point: 265.5 ± 27.8 ° C
Appearance: white crystal
Steam Pressure: 0.0 ± 0.6 mmHg at 25 ° C
Refractive index: 1.603
AstrTransport code of dangerous goods: nonh for all modes of transportagaloside I Safety Information
English Alias of Astragaloside I
asterriquinone dimethyl ether
Customized Service Of Chemical Reference Materials Of Traditional Chinese Medicine
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd. is mainly engaged in the basic research of active substances of traditional Chinese medicine for more than ten years. So far, the company has conducted in-depth research on more than 100 kinds of commonly used traditional Chinese medicine, and extracted thousands of chemical components.
The company has top R & D personnel and perfect testing and analysis equipment in the industry, and has served hundreds of scientific research institutions. It can quickly and efficiently meet the needs of customers
Drug Impurity Separation, Preparation and Structure Confirmation Service
Impurities in drugs are closely related to the quality, safety and stability of drugs. The preparation and structure confirmation of impurities in drugs can help us understand the ways of impurities and provide a basis for the improvement of production process. Therefore, the preparation and separation of impurities is of great significance to drug research and development.
However, the content of impurities in the drug is low, the source is wide, and the structure is mostly similar to the principal component. What technology can be used to separate and purify all impurities in the drug one by one and quickly? What techniques and methods are used to confirm the structure of these impurities? This is the difficulty and challenge faced by many pharmaceutical units, especially the pharmaceutical enterprises of plant medicine and Chinese patent medicine.
Based on such needs, the company has launched drug impurity separation and purification services. Relying on nuclear magnetic resonance, mass spectrometry and other equipment and technologies, the company can quickly identify the structure of the separated compounds, so as to meet the needs of customers.
SPF Animal Experiment
The construction area of the animal experimental area is 1500 square meters, including 400 square meters of SPF level experimental area and 100 square meters of P2 level cell laboratory. Led by scientists of China Pharmaceutical University, it forms a core technical team with a number of returnees. Provide high-quality animal models, experimental design, overall projects and other services for biomedical scientific research, teaching and industrial development.
Scope Of Business
1. Small animal feeding
2. Animal disease modeling
3. College project outsourcing
4. Pharmacodynamic evaluation in vivo
5. Pharmacokinetic evaluation
6. Tumor cell experiment service
1. Focus on real experiments
2. Strictly standardize the process
3. Strictly sign confidentiality agreement
4. Own laboratory without intermediate links
5. The professional technical team guarantees the experimental quality
SPF experimental environment, specially assigned person feeding, real-time tracking experimental progress